Modern Retina

What excites Dr. Weng most about #ProtocolAO—win or lose? From The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, of @BCMDeptMedicine shares why she believes Protocol AO will generate an incredible amount of learning about #wetAMD. hubs.li/Q04v4btk0

The content you rely on is now easier to access. The Eye Care Network brings trusted resources together so you can spend less time searching and more time applying insights that support better patient care. Explore what’s new: hubs.li/Q04svr9T0  #Ophthalmology #EyeCare

Disease mechanisms and treatment goals differ across AMD, DME, and RVO. Our expert panel reviews clinical nuances and how they guide the choice of next-generation anti-VEGF therapy. Watch the discussion: hubs.li/Q04lZc2F0 #Retina #Ophthalmology

How are next-generation anti-VEGF agents changing care in AMD, DME, and RVO? Sharon Fekrat, MD, FACS, FASRS, and an expert panel discuss the real-world performance, durability, and safety of aflibercept 8 mg and faricimab. Watch now: hubs.li/Q04jplPR0 #Retina #AntiVEGF

As aesthetic injectables continue to grow in popularity, retina specialists are increasingly likely to encounter patients considering these procedures. Watch the latest episode of The Retina TL;DR to learn more: hubs.li/Q04gSSyR0

Jennifer Murdock, MD, joins The Retina TL;DR with Christina Y. Weng, MD, MBA, FASRS, to discuss filler-related ocular complications, high-risk injection sites, emergency management strategies, and more. Watch now: hubs.li/Q04gSpP00

Watch Christina Y. Weng, MD, MBA, FASRS, and her guest Jennifer Murdock, MD, discuss anatomy, vascular occlusion risk, and periocular filler safety in the latest episode of The Retina TL;DR: hubs.li/Q04gSC8Q0

Prevent Blindness has designated April as Women’s Eye Health and Safety Month. We are proud to support this initiative and highlight the voices shaping the future of care. Explore insights from female key opinion leaders whose recent work is featured on our platforms.

We are hosting two events for retina specialists in Fort Lauderdale, FL, on May 15. Participants will receive $500 in compensation. Learn more and join us! Geographic Atrophy Roundtable: hubs.li/Q04dq6Sv0 Anti-VEGF Roundtable: hubs.li/Q04dqkxz0

Honoring the women who are shaping the future of vision. From groundbreaking research to everyday patient care, their leadership and dedication continue to move the field forward. This Women’s History Month, we recognize their impact across every corner of eye care.

Check out the latest issue of Modern Retina! Read about how AI is reshaping ophthalmology, mitigating severe vision loss, multimodal imaging for AMD and GA, as well as mentorship, momentum, and a retina podcast. Read now: hubs.li/Q0450NXy0 #Retina #VisionLoss #AMD #GA

Disease mechanisms and treatment goals differ across AMD, DME, and RVO. Our expert panel reviews clinical nuances and how they guide the choice of next-generation anti-VEGF therapy. Watch the discussion: hubs.li/Q03_z0wF0 #Retina #Ophthalmology

Our latest issue is live! Read about the science powering next-generation retinal treatments, custom programs for managing Macular Telangiectasia, and treatment options for reducing fluid fluctuation in retinal disorders. Read now: hubs.li/Q03ZZ87N0 #Retina #MacTel

How are next-generation anti-VEGF agents changing care in AMD, DME, and RVO? Sharon Fekrat, MD, FACS, FASRS, and an expert panel discuss the real-world performance, durability, and safety of aflibercept 8 mg and faricimab. Watch now: hubs.li/Q03Y_T990 #Retina #AntiVEGF

Wishing you a season filled with clear moments and bright perspectives. 🎄👁️ Thank you to the retina specialists whose precision and dedication protect sight at its most critical level, today and all year long. #EyeCareProfessionals #RetinaCare #HappyHolidays

Grateful for the eye-care professionals who bring clarity, comfort, and better vision to patients every day. Wishing you a spec-tacular 👓 and restorative Thanksgiving! 🦃 #thanksgiving #eyecare

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such as wet age-related macular degeneration (wAMD) and diabetic macular edema (DME). hubs.li/Q03Vn_yh0

Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients. hubs.li/Q03Vp8Yp0

Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME: hubs.li/Q03Vn_TX0

Q&A: Kenneth Fan on MCO-010 trials for Stargardt disease: hubs.li/Q03VhpLR0